Press release
Emerging Sub-Segments Transforming the Deep Brain Stimulation Market for Parkinson's Disease
Deep Brain Stimulation In Parkinson`s Disease Market
Projected Growth and Market Size of Deep Brain Stimulation in Parkinson's Disease
The deep brain stimulation market for Parkinson's disease is anticipated to expand significantly, reaching a valuation of $4.49 billion by 2030. This growth reflects a compound annual growth rate (CAGR) of 6.4%. The upward trend is fueled by increasing demand for personalized neuromodulation treatments, greater investments in research and clinical trials, broader access to tele-neurology services, expansion of reimbursement policies, and rising use of MRI-compatible and rechargeable devices. Additionally, key trends shaping this market include advances in closed-loop and directional stimulation systems, improvements in rechargeable implantable pulse generators (IPGs) with longer battery lives, adoption of AI-assisted DBS programming, innovations in minimally invasive surgical methods, and enhanced remote monitoring and telemedicine technologies.
Download a free sample of the deep brain stimulation in parkinson`s disease market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30568&type=smp
Leading Companies Influencing the Deep Brain Stimulation Parkinson's Disease Market
Several prominent players dominate the deep brain stimulation market for Parkinson's disease. These include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Mayo Foundation for Medical Education and Research, Cleveland Clinic, Renishaw plc, Neuralink Corp., NeuroPace Inc., PINS Medical Co. Ltd., Neurosoft Ltd., BrainsWay Ltd., Medscape, Inomed Medizintechnik GmbH, SceneRay Corporation Ltd., Neuroelectrics Barcelona S.L., Soterix Medical Inc., CorTec GmbH, Aleva Neurotherapeutics SA, NeuroSigma Inc., and BrainGate Company Inc. These organizations are actively advancing research and product development to meet evolving patient needs.
Emerging Innovations and Trends Steering the Parkinson's Disease DBS Market
Companies within the deep brain stimulation domain are increasingly focusing on miniaturizing rechargeable implantable pulse generators to improve patient comfort and facilitate less invasive implantation. These smaller devices maintain robust functionality while reducing the physical burden on patients. Another key trend is the integration of remote programming technologies that allow for treatment adjustments without requiring hospital visits.
View the full deep brain stimulation in parkinson`s disease market report:
https://www.thebusinessresearchcompany.com/report/deep-brain-stimulation-in-parkinsons-disease-market-report
For example, in January 2024, Abbott Laboratories introduced the Liberta RC DBS system, a compact rechargeable deep brain stimulation device equipped with remote programming capabilities. This system targets individuals with movement disorders such as Parkinson's disease and essential tremor. Notably, it offers the longest recharge interval among FDA-approved DBS systems, typically requiring only 10 recharge sessions annually. The platform also features the NeuroSphere Virtual Clinic, which enables patients to consult with their healthcare providers and receive therapy modifications remotely from home.
Segment Breakdown and Market Analysis for DBS in Parkinson's Disease
The deep brain stimulation market for Parkinson's is segmented by various criteria to provide detailed insights. Key categories include:
1) By Component: Software and Service
2) By Deployment Model: On-Premises and Cloud
3) By Enterprise Size: Small and Medium Enterprises (SMEs) and Large Enterprises
4) By Application: Budgeting and Forecasting, Risk Management, Strategic Planning, and Performance Management
Further subsegments under software include financial scenario simulation tools, predictive analytics platforms, budgeting and forecasting systems, and performance monitoring software. For services, subcategories encompass implementation and integration, consulting and advisory, support and maintenance, training and skill development, and managed financial planning services.
This segmentation offers a comprehensive perspective on the various facets of the market, highlighting opportunities and areas of innovation within the deep brain stimulation landscape for Parkinson's disease.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Sub-Segments Transforming the Deep Brain Stimulation Market for Parkinson's Disease here
News-ID: 4368333 • Views: …
More Releases from The Business Research Company
Emerging Growth Patterns Driving Rapid Expansion in the Cognitive Neuroscience M …
The cognitive neuroscience market is poised for significant growth as advances in technology and research continue to reshape the field. With increasing applications across healthcare and research, this sector is attracting substantial investment and innovation, setting the stage for notable expansion through 2030.
Projected Growth and Expansion of the Cognitive Neuroscience Market
The cognitive neuroscience market is forecasted to reach a value of $35.02 billion by 2030, growing at a…
Segmentation, Major Trends, and Competitive Overview of the Artificial Intellige …
The artificial intelligence (AI) safety market is on the cusp of remarkable expansion, driven by increasing demand for secure, reliable, and transparent AI systems. As industries continue to integrate AI technologies, ensuring these systems operate safely and ethically is becoming a top priority. Let's explore the projected market size, key players, influential trends, and segmentation details shaping the future of AI safety.
Expected Market Size and Growth Trajectory in the Artificial…
Market Trend Analysis: The Impact of Recent Innovations on the Artificial Intell …
The integration of artificial intelligence (AI) into spintronics is emerging as a transformative trend with the potential to revolutionize memory and computing technologies. As AI continues to evolve, its application in spintronics is expected to unlock new capabilities in energy efficiency, data storage, and computational power. Let's explore the forecasted market growth, key players, technological advancements, and the primary segments shaping this innovative field.
Projected Market Size and Growth Trajectory for…
Artificial Intelligence (AI) in Arrhythmia Burden Analytics: Market Overview, Em …
The artificial intelligence (AI) arrhythmia burden analytics sector is set to experience remarkable growth over the coming years, driven by technological advancements and increasing adoption in healthcare. This rapidly evolving field is transforming cardiac care by offering more precise, efficient, and personalized diagnostic solutions. Below is an in-depth look at the market size, key players, trends, and segmentation shaping this industry's future.
Market Size Outlook and Expected Growth for the Artificial…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
